A LinkedIn post from FluoretiQ Limited describes the TAP program going live at Rase Vets Market Rasen, featuring the Veri-5 Vet diagnostic instrument. The post highlights comments from a lab technician who characterizes the system as a potential “lifesaver” by accelerating sample handling and result turnaround.
According to the post, Veri-5 Vet is intended to replace manual laboratory processes that can take up to five days, suggesting a shift toward more efficient workflows in veterinary diagnostics. Faster results may enhance patient care and could strengthen FluoretiQ’s value proposition with veterinary practices seeking operational efficiency.
For investors, the deployment at Rase Veterinary Centre may indicate early commercial traction and real-world validation of FluoretiQ’s technology. If such installations scale, the company could benefit from recurring equipment and consumable revenues, while improving its competitive position in the veterinary lab equipment segment.
The promotional nature of the content, including a call to register interest in the program, suggests FluoretiQ is actively marketing Veri-5 Vet to additional clinics. Future updates on adoption rates, pricing, and regulatory or performance data would be important for assessing revenue potential and longer-term financial impact.


